# Patient-Derived Breast Cancer Organoids for Therapeutic Extracellular Vesicle Isolation (PDO-Mercurial01)

> **NCT07421479** · — · ACTIVE_NOT_RECRUITING · sponsor: **Istituti Clinici Scientifici Maugeri SpA** · enrollment: 50 (estimated)

## Conditions studied

- Invasive Breast Cancer

## Interventions

- **PROCEDURE:** Blood and tumor tissue collection

## Key facts

- **NCT ID:** NCT07421479
- **Lead sponsor:** Istituti Clinici Scientifici Maugeri SpA
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-01-01
- **Primary completion:** 2027-10-28
- **Final completion:** 2027-10-28
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07421479

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07421479, "Patient-Derived Breast Cancer Organoids for Therapeutic Extracellular Vesicle Isolation (PDO-Mercurial01)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07421479. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*